Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells. 2004

Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
Department of Chemistry, Boehringer Ingelheim (Canada) Ltd., Research and Development, 2100 Cunard Street, Laval, Québec, Canada H7S2G5. pbeaulieu@lav.boehringer-ingelheim.com

A previously disclosed series of non-nucleoside allosteric inhibitors of the NS5B polymerase of the hepatitis C virus (HCV) was optimized to yield novel compounds with improved physicochemical properties and activity in cell-based assays. Replacement of ionizable carboxylic acids with neutral substituents in lead compounds produced inhibitors with cellular permeability and antiviral activity in a cell-based assay of subgenomic HCV RNA replication (replicon EC(50) as low as 1.7 microM). The improvement in potency in this ex vivo model of HCV RNA replication validates, in part, the mechanism by which this class of allosteric benzimidazole derivatives inhibits the polymerase and represents a significant step forward in the discovery of novel HCV therapeutics.

UI MeSH Term Description Entries
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins

Related Publications

Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
May 2003, Journal of virology,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
March 2012, Journal of medicinal chemistry,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
March 2006, Infectious disorders drug targets,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
April 2017, Journal of medicinal chemistry,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
November 2004, Journal of viral hepatitis,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
October 2003, Journal of virology,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
January 2015, Archiv der Pharmazie,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
July 2005, Journal of medicinal chemistry,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
May 2006, Biochemical and biophysical research communications,
Pierre L Beaulieu, and Yves Bousquet, and Jean Gauthier, and James Gillard, and Martin Marquis, and Ginette McKercher, and Charles Pellerin, and Serge Valois, and George Kukolj
August 2006, Journal of molecular biology,
Copied contents to your clipboard!